Median Technologies inks a collaboration agreement with Memorial Sloan Kettering Cancer Center for a study dealing with prostate cancer
Median Technologies, The Imaging Phenomics Company® (Paris:ALMDT) announces today that the company has signed a collaboration agreement with the New York City based Memorial...
Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate
Takeda Pharmaceutical Company Limited announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a Phase 1 clinical trial,...
Synpromics announces collaboration with UCL to develop revolutionary gene therapy for Parkinson’s Disease
Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system...
Merck Kgaa, Darmstadt, Germany, And Pfizer Provide Update On Phase III Javelin Gastric 300
Merck KGaA, Darmstadt, Germany, and Pfizer Inc announced that the Phase III JAVELIN Gastric 300 trial did not meet its primary endpoint of superior...
Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis
Biogen and Alkermes plc announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700, a novel,...
Receptor tyrosine kinase-like orphan receptor 1-derived peptide as target for the design of cytotoxic T cell-based immunotherapy
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults. It is due to the growth of neoplastic B cells in...
AstraZeneca and Chinese Future Industry Investment Fund establish joint venture to develop new medicines in China
AstraZeneca announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China to discover,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...